Two Pharmaceutical giants have partnered with Amazon Web Services and their machine learning technology to better test for effective therapies for difficult diseases. Pharmaceutical company Takeda and research and development institute ConvergeHEALTH by Deloitte are in the pursuit of finding answers and treatments for some of the most prevalent diseases in the world. With the help of insurance claims information including diagnoses, medical procedures and prescriptions AWS can run linear and non-linear models on disease data sets to identify factors with the highest impact on predicting patient outcomes.
The companies are using claims data sets with the combination of machine learning to build models that can predict and determine certain patients that may be resistant to certain depression medications and which ones would work best for them. Dan housman of ConvergeHEALTH states “The benefit to the patient is a shorter journey to a drug that will keep them well and less time struggling with their depression,” Housman explained. “The benefit to Takeda is to be able to build tools both with guidelines or decision support systems to help physicians find the patients who can benefit from our products.”
